ABMC | tickerfilter.com

Fundamental analysis

Profitability 0%

Dept financing 0%

Liquidity 0%

Performance 20%

Performance

5 Days

0 0%

1 Month

-100.00%

3 Months

-100.00%

6 Months

-100.00%

1 Year

-100.00%

2 Year

-100.00%

Key data

Stock price

$0.00

P/E Ratio

N/A

DAY RANGE

$0.00 - $0.00

EPS

N/A

52 WEEK RANGE

$0.00 - $0.00

52 WEEK CHANGE

-$100.00

MARKET CAP

0.000

YIELD

N/A

SHARES OUTSTANDING

0.000

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

0.00

PUBLIC FLOAT

N/A

AVERAGE 10 VOLUME

$1,000

AVERAGE 30 VOLUME

$3,950

Company detail

CEO:
Region: US
Website: abmc.com
Employees: 30
IPO year: 2009

Issue type:
Market: OTCM
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

American Bio Medica Corporation engages in manufacture and sale of lateral flow immunoassay tests. Its drugs detection products in urine include Rapid Drug Screen, a rapid drug test, which detects the presence or absence of 2 to 10 drugs. The company also offers OralStat, a drug test for the detection of drugs in oral fluids, as well as private labeled versions of OralStat. It operates in the United States, Europe, Asia Pacific, and South America.

ABMC - AMERICAN BIO MEDICA CORP